-

Michael Heinley Joins Sam Brown Healthcare Communications As Managing Director, Client Development and Engagement

-- Heinley to focus on strategic growth, and joins the leadership team of Sam Brown, a Blue Matter Company --

WAYNE, Pa. & NEW YORK--(BUSINESS WIRE)--Sam Brown Healthcare Communications, a Blue Matter Company, is proud to announce the appointment of Michael Heinley to the new position of Managing Director, Client Development and Engagement, reporting to Founder and President Laura Liotta.

With deep in-house and agency PR experience in the life sciences industry, Heinley is a highly seasoned counselor with a proven record of strategic communications impact across leading global organizations. These include senior leadership roles at Johnson & Johnson, Merck & Co., Inc., and WebMD. Most recently, as Senior Partner in the Finn Partners Global Health Practice, he led client development and engagement for pharmaceutical, biotech, health tech, med tech, health systems, professional societies, and advocacy organizations.

“In today’s fast-moving and complex healthcare environment, Michael has a distinct perspective leading corporate, scientific, marketing, and brand storytelling campaigns that build trust, strengthen reputation, and deliver meaningful business results,” said Laura Liotta, Founder and President of Sam Brown. “In this new role at Sam Brown, Michael will be instrumental in delivering innovative solutions, expanding our services and markets globally, and enabling our integrated teams to help clients adapt and lead in an evolving landscape.”

Throughout his career, Heinley oversaw multiple global pharmaceutical product launches, R&D communications, employee engagement, financial/IR communications, reputation and issues management, CEO and C-suite counsel, and executive thought leadership.

Heinley was named among the industry’s most influential leaders and Mentor of the Year by PM360. He currently serves on the Board of Directors for Donate Life New York State, a statewide nonprofit dedicated to increasing organ and tissue donation.

“I’m thrilled to join the talented team at Sam Brown to help drive the agency’s continued growth and success,” said Heinley. “Under Laura’s leadership, I’ve deeply admired the ‘Sam Brownie’ culture—recognized for building and sustaining enduring client partnerships through strategic expertise, hands-on senior counsel, and integrated creative excellence.”

About Sam Brown Healthcare Communications

For 26 years, Sam Brown has been a leading healthcare-focused corporate, clinical, and commercial communications agency for the life sciences industry. Sam Brown provides broad strategic communications services to a wide range of biotechnology, biopharmaceutical, and venture capital companies whose cutting-edge science and innovation impact human health. For more information, visit www.sambrown.com.

About Blue Matter

Blue Matter is a strategic consulting firm serving the life sciences industry. From its offices in North America, Europe and Asia, Blue Matter serves pharmaceutical and biotech companies from around the globe. The firm helps clients maximize value at the product, portfolio, and organization levels. It has broad therapeutic expertise with a focus on complex markets such as oncology, CNS, and rare diseases. For more information, visit www.bluematter.com.

Contacts

Media Contact:
Christy Curran
Sam Brown Inc.
615.414.8668
christycurran@sambrown.com

Sam Brown Healthcare Communications


Release Versions

Contacts

Media Contact:
Christy Curran
Sam Brown Inc.
615.414.8668
christycurran@sambrown.com

More News From Sam Brown Healthcare Communications

Blue Matter Expands Capabilities in Healthcare Policy Support for Life Sciences Led by Partner, Milena Sullivan

NEW YORK--(BUSINESS WIRE)--Blue Matter today announced the launch of an expanded policy capability to support biopharma clients, led by Milena Sullivan, a Partner who joined the firm in December 2025. Milena Sullivan brings more than 20 years of experience in healthcare policy, advocacy, and market access, advising life science companies, trade associations, and provider organizations on policy issues shaping their business. Prior to joining Blue Matter, she spent almost a decade with Avalere H...

AIM Expands Life Sciences Supply Chain Capabilities and Hires New Partner, Thomas Ebel

ROTTERDAM, Netherlands--(BUSINESS WIRE)--AIM today announced the appointment of veteran pharma supply chain expert Thomas Ebel as Partner, effective June 15. Mr. Ebel brings more than 25 years of supply chain consulting experience at leading firms including CAMELOT, McKinsey, and Accenture, and will anchor a broader initiative to expand AIM’s end-to-end supply chain capabilities. According to Richard de Bakker, Statutory Director and Founder at AIM, the firm is significantly expanding its capab...

Blue Matter Launches People and Organization Practice to Help Biopharma Navigate Structural Shift

NEW YORK--(BUSINESS WIRE)--Blue Matter today announced the launch of its People and Organization Practice, a dedicated capability designed to help life science companies build organizations that can perform through complexity - from enterprise transformation and M&A integration to talent strategy, learning, and workforce redesign. The launch reflects a central conviction: the biopharma industry is not experiencing a cyclical downturn but a structural shift. With more than 42,700 jobs cut ac...
Back to Newsroom